Tazidime and Bone - broken - a phase IV clinical study of FDA data

Summary:

Bone - broken is reported as a side effect among people who take Tazidime (ceftazidime), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Breast cancer.

The phase IV clinical study analyzes which people have Bone - broken when taking Tazidime. It is created by eHealthMe based on reports of 10,389 people who have side effects when taking Tazidime from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Bone - broken?

Bone - broken is found to be associated with 2,054 drugs and 1,507 conditions by eHealthMe. Check the latest studies of Bone - broken.

On Jun, 18, 2026

10,389 people reported to have side effects when taking Tazidime.
Among them, 7 people (0.07%) have Bone - broken.

Among these 7 people:

How long have people been on Tazidime when they have Bone - broken? *

What is the gender of people who have Bone - broken when taking Tazidime? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Bone - broken when taking Tazidime? *

What are other drugs people take besides Tazidime? *

What are other side effects people have besides Bone - broken? *

Constipation: 3 people, 42.86%
Anaemia (lack of blood): 3 people, 42.86%
Death: 3 people, 42.86%
Nausea (feeling of having an urge to vomit): 3 people, 42.86%
Pain In Extremity: 3 people, 42.86%
Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 3 people, 42.86%
Stress And Anxiety: 3 people, 42.86%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 42.86%
Insomnia (sleeplessness): 3 people, 42.86%
Indigestion: 3 people, 42.86%

What are the existing conditions these people have? *

Breast Cancer: 2 people, 28.57%
Stress And Anxiety: 1 person, 14.29%
Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 1 person, 14.29%
Pain: 1 person, 14.29%
Hiv Infection: 1 person, 14.29%
Fungal Infection: 1 person, 14.29%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 14.29%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and have Bone - broken?

- Check whether Bone - broken is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazidime:

Tazidime (10,409 reports)

Bone - broken treatments and more:

Bone - broken (35,552 reports)

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone - broken:

Bone - broken (2,054 drugs)

Browse all the conditions that are associated with Bone - broken:

Bone - broken (1,507 conditions)

Related publications that referenced our studies

Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Tazidime) and Tazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.